Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ALV | PRESS-RELEASE | neutral | 2/10 | Autoliv declared a quarterly dividend of $0.87 per share for Q3 2026, payable September 15/16 to holders of record Augus | Aug 13, 2026 |
| BTQ | PRESS-RELEASE | neutral | 2/10 | BTQ Technologies released its 2026 AGM results, which is a routine governance filing. The document covers the election o | Aug 13, 2026 |
| WY | PRESS-RELEASE | neutral | 2/10 | Weyerhaeuser declared a quarterly base cash dividend of $0.21 per share, payable September 18, 2026. The company reaffir | Aug 13, 2026 |
| OGGWZ | PRESS-RELEASE | neutral | 4/10 | Osisko Gold Group (OGGWZ) reported Q2 2026 revenue of $32.7M, up from $6.9M in Q2 2025, driven by gold sales from small- | Aug 13, 2026 |
| BBIO | PRESS-RELEASE | bearish | 5/10 | BridgeBio announced a secondary offering of 5,000,000 shares by KKR Genetic Disorder L.P., with the company receiving no | Aug 13, 2026 |
| ALOY | PRESS-RELEASE | mixed | 6/10 | REalloys reported Q2 2026 revenue of $0.8M (up from $0.4M YoY) but a net loss of $36.8M ($0.59/share), far worse than th | Aug 13, 2026 |
| BCG | PRESS-RELEASE | neutral | 4/10 | Binah Capital Group reported Q2 2026 results with revenue of $46.5M (+12.1% YoY) and net income of $0.3M, a 152% improve | Aug 13, 2026 |
| AIRJ | PRESS-RELEASE | bearish | 6/10 | AirJoule Technologies reported a GAAP net loss of $8.5M for Q2 2026, with EPS of -$0.12, significantly missing the conse | Aug 13, 2026 |
| CTNT | PRESS-RELEASE | bearish | 7/10 | Cheetah Net Supply Chain Services reported Q2 2026 revenue of $868,909, up 145.4% YoY, driven by the newly acquired inte | Aug 13, 2026 |
| API | PRESS-RELEASE | neutral | 5/10 | Agora reported Q2 2026 revenue of $40.4M (+18% YoY) and net income of $2.2M, marking its seventh consecutive GAAP-profit | Aug 13, 2026 |
| DGNX | PRESS-RELEASE | bearish | 6/10 | Diginex reported FY2026 revenue of $3.6M (+77% YoY) but net loss widened to $31.1M from $5.2M, driven by $7M goodwill im | Aug 13, 2026 |
| IMCC | PRESS-RELEASE | bearish | 7/10 | IM Cannabis Corp. reported Q2 2026 revenue of $7.6M (down 40% YoY from $12.7M) and a net loss of $4.4M ($0.47/share), wi | Aug 13, 2026 |
| GEMI | PRESS-RELEASE | mixed | 6/10 | Gemini Space Station reported Q2 2026 revenue of $45.5M, beating the $43.5M consensus, but EPS of -$0.89 missed the -$0. | Aug 13, 2026 |
| GNLX | PRESS-RELEASE | neutral | 4/10 | Genelux reported Q2 2026 net loss of $0.21 per share, slightly below the $0.20 consensus estimate. The pre-revenue clini | Aug 13, 2026 |
| ASNS | PRESS-RELEASE | mixed | 5/10 | Actelis Networks reported Q2 2026 revenue of $1.1M (+20% YoY) and a GAAP EPS of -$0.05, beating the -$0.16 consensus est | Aug 13, 2026 |
| CVU | PRESS-RELEASE | bullish | 6/10 | CPI Aerostructures reported Q2 2026 revenue of $17.6M (+15.8% YoY) and net income of $0.7M vs a $(1.3M) loss last year, | Aug 13, 2026 |
| CLDI | PRESS-RELEASE | mixed | 5/10 | Calidi Biotherapeutics reported Q2 2026 results with a narrowed net loss of $4.2M ($2.94/share) vs $5.7M ($31.75/share) | Aug 13, 2026 |
| SDST | PRESS-RELEASE | bearish | 6/10 | Stardust Power reported Q2 2026 EPS of -$0.35, beating the -$0.39 consensus estimate, but the company remains pre-revenu | Aug 13, 2026 |
| TIL | PRESS-RELEASE | neutral | 4/10 | Instil Bio reported Q2 2026 GAAP net loss of $0.63 per share, narrowing from a $3.24 loss in Q2 2025, driven by sharply | Aug 13, 2026 |
| BKYI | PRESS-RELEASE | mixed | 5/10 | BIO-key reported Q2 2026 revenue of $1.92M, beating the $1.8M consensus by 6.7%, and EPS of -$0.56 (post-split), which w | Aug 13, 2026 |
| TPST | PRESS-RELEASE | bearish | 7/10 | Tempest Therapeutics reported Q2 2026 net loss of $5.2M ($0.34/share), a narrower loss vs $7.9M ($2.07) a year ago, but | Aug 13, 2026 |
| SKE | PRESS-RELEASE | bearish | 6/10 | Skeena Resources reported Q2 2026 EPS of -$0.30, significantly missing the consensus estimate of -$0.09 (a 233% miss), c | Aug 13, 2026 |
| CWD | PRESS-RELEASE | bearish | 6/10 | Caliber (CWD) reported Q2 2026 platform revenue of $3.7M, down from $4.1M YoY, and a platform net loss of $0.39 per shar | Aug 13, 2026 |
| INBX | PRESS-RELEASE | bearish | 6/10 | Inhibrx reported Q2 2026 EPS of -$2.34, a 26.5% miss vs the -$1.85 year-ago period, and zero revenue (vs $1.3M in Q2 202 | Aug 13, 2026 |
| VUZI | PRESS-RELEASE | mixed | 5/10 | Vuzix reported Q2 2026 revenue of $1.1M, down 14% YoY, and a net loss of $0.09 per share, beating the consensus estimate | Aug 13, 2026 |
| DWSN | PRESS-RELEASE | mixed | 5/10 | Dawson Geophysical reported Q2 2026 revenue of $17.9M (+82% YoY) and a net loss of $3.4M ($0.11/share), which included $ | Aug 13, 2026 |
| GLOB | PRESS-RELEASE | bearish | 7/10 | Globant reported Q2 2026 Non-IFRS Adjusted Diluted EPS of $1.40, missing consensus of $1.50 by 6.5%, while revenue of $6 | Aug 13, 2026 |
| NKTR | PRESS-RELEASE | bullish | 7/10 | Nektar Therapeutics reported Q2 2026 EPS of -$1.23, a 39.6% beat vs consensus of -$2.04, on revenue of $10.1M (slightly | Aug 13, 2026 |
| AEMD | PRESS-RELEASE | neutral | 4/10 | Aethlon Medical reported Q1 FY2027 EPS of -$4.02, slightly beating the -$4.05 consensus estimate, with operating expense | Aug 13, 2026 |
| HIT | PRESS-RELEASE | bearish | 6/10 | Health In Tech reported Q2 2026 revenue of $8.1M (down 13.5% YoY from $9.3M) and a net loss of $2.5M ($-0.04 EPS), rever | Aug 13, 2026 |